PetMed Express, Inc. (PETS) is a publicly traded Healthcare sector company. As of October 3, 2026, PETS trades at $1.35 with a market cap of $29.70M and a P/E ratio of -0.98. PETS moved -1.09% today. Year to date, PETS is -58.79%; over the trailing twelve months it is -47.69%. Its 52-week range spans $1.33 to $5.43. Analyst consensus is sell with an average price target of $2.15. Rallies surfaces PETS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PetMeds grants CEO Willard 250,000 restricted shares and 250,000 performance share units: PetMed Express granted newly hired CEO Jeff Willard 250,000 restricted shares and 250,000 performance share units under its inducement plan. The company also granted new CTO Andrew Parry 100,000 restricted shares.
| Metric | Value |
|---|---|
| Price | $1.35 |
| Market Cap | $29.70M |
| P/E Ratio | -0.98 |
| EPS | $-1.38 |
| Dividend Yield | 0.30% |
| 52-Week High | $5.43 |
| 52-Week Low | $1.33 |
| Volume | 177.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $168.86M |
| Net Income | $-29.28M |
| Gross Margin | 27.92% |
1 analysts cover PETS: 0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $2.15.